Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-25-016522
Filing Date
2025-04-30
Accepted
2025-04-30 07:47:17
Documents
21
Period of Report
2025-06-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20045223x1_def14a.htm   iXBRL DEF 14A 1462944
4 logo_ardelyxsymbol.jpg GRAPHIC 20032
5 ny20045223x1_piecharts01.jpg GRAPHIC 118766
6 ny20045223x1_pc01.jpg GRAPHIC 669356
7 ny20045223x1_pc02.jpg GRAPHIC 450026
8 ny20045223x1_pvp01x1.jpg GRAPHIC 145956
9 ny20045223x1_pvp02x1.jpg GRAPHIC 145816
10 ny20045223x1_pvp03x1.jpg GRAPHIC 141870
  Complete submission text file 0001140361-25-016522.txt   6421720

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA ardx-20250618.xsd EX-101.SCH 2822
3 INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE ardx-20250618_def.xml EX-101.DEF 1903
23 EXTRACTED XBRL INSTANCE DOCUMENT ny20045223x1_def14a_htm.xml XML 123397
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36485 | Film No.: 25891038
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)